Zivo Bioscience, Inc. (ZIVO)
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
ZIVO Bioscience, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 3.89M shares outstanding
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods.
The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being.
Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014.
Its corporate operations are based in Bloomfield Hills, Michigan.
Leadership
Alison A. Cornell
Director
Christopher D. Maggiore
Director
John B. Payne
President and Chief Executive Officer / Chairman / Director
Keith R. Marchiando
Chief Financial Officer
Employees
7
Country
US
Sector
Healthcare
Website
zivobioscience.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| 10% Owner | Purchase | 100.0K | $200.0K | Apr 17, 2026 | |
| Director | Purchase | 1.5K | $15.0K | Feb 27, 2026 | |
| 10% Owner | Purchase | 2.0K | -- | Feb 12, 2026 | |
| 10% Owner | Purchase | 20.0K | $195.4K | Feb 12, 2026 | |
| Director | Purchase | 2.4K | $25.0K | Feb 10, 2026 | |
| Director | Purchase | 11.7K | $100.0K | Jan 26, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
YALDOO LAITH L Director, 10% Owner | 542.1K | 13.9% | FORM 4 |
HEP Investments LLC 45-3135062 · may incl. warrants· stale · filed Oct 2024 | 531.0K | 13.7% | 13D |
Mark E. Strome · may incl. warrants· filed Feb 2026 | 472.9K | 12.2% | 13D |
Christopher D. Maggiore · may incl. warrants· stale · filed Jun 2024 | 458.4K | 11.8% | 13D |
Keith Marchiando · may incl. warrants· stale · filed Jun 2024 | 341.6K | 8.8% | 13D |
John Bernard Payne · may incl. warrants· stale · filed Jun 2024 | 305.9K | 7.9% | 13D |
Alison A. Cornell · may incl. warrants· stale · filed Jun 2024 | 242.2K | 6.2% | 13D |
Masterson Nola E Director | 130.9K | 3.4% | FORM 4 |
CoreCap Advisors, LLC | 4.4K | 0.1% | 13F |
Insiders
- STROME MARK E10% Owner
- YALDOO LAITH LDirector
- Cornell Alison ADirector
- PAYNE JOHN BERNARDPresident and CEO
- Maggiore Christopher D.Director
- Masterson Nola EDirector
Top institutional holders
based on 3.89M shares outstanding
30d Avg
1.37K
60d Avg
1.15K
90d Avg
1.04K